2023-504782-23-00CompletedPhase 1
A study of how CagriSema works on appetite in people with excess body weight
Source: EU CTIS (euclinicaltrials.eu) · Last updated 30 Sept 2025
- Status (registry)
- Completed
- Phase (registry)
- Phase 1
- Study type
- Interventional
- Enrollment
- 150 (actual)
- First submitted
- 25 Sept 2023
- Start date
- 9 Feb 2024
- Lead sponsor
- Novo Nordisk A/S
- Diseases
- Obesity
- EU CT number
- 2023-504782-23-00
What you commit to
- Study type: Interventional · Phase 1
- Participants enrolled: 150
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of EU CTIS (euclinicaltrials.eu). It describes the study design.
Sites (1)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Charite Research Organisation GmbH | Berlin | Germany | Completed |
This page is information, not medical advice. Discuss any trial with your doctor.